The present invention relates to compounds for their use in the prevention and/or treatment of ischemia/reperfusion injury of a tissue or an organ in a subject, wherein said compounds are statins, statin derivatives, agents inhibiting RhoA translocation to the cell membrane, agents increasing PKCε activity or any combination thereof, administered to the subject in need thereof prior to reperfusion.